Login to Your Account



All's not NSAID and done? Better drug from old class trailing Inspirion win

By Randy Osborne
Staff Writer

Wednesday, April 26, 2017

With the urgency rising for abuse-deterrent opioids in an overdose-ridden world, Inspirion Delivery Sciences LLC gained a key approval and Antibe Therapeutics Inc. began work that CEO Dan Legault told BioWorld Today could help "solve this elusive problem."

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription